The U.S. Preventive Services Task Force does one thing that matters enormously to ordinary Americans: it decides which medical screenings, preventive treatments, and health services private insurers must cover at no out-of-pocket cost under the Affordable Care Act. Mammograms. Colorectal cancer screenings. Blood pressure checks. Depression screenings for pregnant women. The task force's recommendations, built from clinical evidence by independent physicians and researchers, are the mechanism by which preventive care reaches people who would otherwise skip it because of cost. On May 11, Health Secretary Robert F. Kennedy Jr. fired its two co-chairs.
According to Axios, Kennedy sent letters to John Wong, a professor and primary care clinician at Tufts University, and Esa Davis, a professor and primary care clinician at the University of Maryland, informing them that their appointments as co-chairs concluded effective immediately. Wong's term was not scheduled to end until mid-March 2027. Davis's ran through mid-March 2028. Neither was given a performance-based reason. The letters stated the dismissals followed a review of current task force appointments and were taken, in the Department's own words, to "help protect the Task Force and preserve confidence in the continuity and durability of its work." The Department of Health and Human Services confirmed the firings but did not respond to follow-up questions.
The U.S. Preventive Services Task Force is an independent panel of primary care physicians and public health experts that reviews clinical evidence and recommends which preventive health services insurers must cover without cost-sharing under the Affordable Care Act. Its recommendations affect hundreds of millions of Americans with private insurance. The Supreme Court upheld the HHS secretary's authority to remove and replace task force members in 2025.
The timing is the story. Kennedy's HHS has postponed the last several meetings of the task force. Applications for new members opened last month and close this Saturday, with new terms beginning in June. The co-chairs would ordinarily be central to vetting incoming applicants. They have now been removed before that process concludes — meaning the selection of the people who will shape the task force's future composition will happen without the independent scientific leadership that would typically govern it. The HHS secretary, who fired those chairs, now effectively controls who fills those seats.
Aaron Carroll, president of AcademyHealth, told Axios what that means in practice: "It could lead to political influence. It could lead to less rigor in the guidelines. It could lead to evidence being used or misused to not only make recommendations but determine what Americans get covered by insurance without copay, and what prevention they will or will not have." Carroll also flagged a practical governance problem: it is not clear how new members will be chosen at all without active task force chairs in place.
This is the pattern worth naming directly. The task force is not an advisory committee that produces reports. It is a regulatory mechanism. Its recommendations carry legal force under the ACA: a favorable rating translates into a mandate that insurers cover the service at zero cost to the patient. That is a substantial market intervention — one that benefits patients and constrains insurer profits. The body that makes those decisions has, until now, been structured to resist political interference. What Kennedy has done is not merely a personnel change. It is a structural alteration of who controls that mechanism.
The letters Kennedy sent are worth reading closely. They do not allege misconduct. They do not cite a change in policy direction or a disagreement about the task force's work. They invoke administrative review and the need to "preserve confidence" in the body's work. That language is doing a specific kind of work: it frames the dismissal as protective rather than political, institutional rather than ideological. It is the bureaucratic grammar of a power grab dressed as housekeeping.
Kennedy's track record at HHS makes the stakes concrete. As Tinsel News has documented, measles and whooping cough outbreaks have surged in states that adopted his vaccine policies — a direct consequence of eroding evidence-based public health infrastructure. The task force firing fits the same logic: remove the independent scientific gatekeepers, replace them with appointees who serve at the secretary's pleasure, and the recommendations that follow will reflect political priorities rather than clinical evidence. The question is not whether that will happen. The question is what the consequences will be when it does.
Consider what a politically managed task force could do. It could decline to recommend coverage for contraception — a live political target for this administration. It could weaken coverage mandates for gender-affirming care. It could narrow or eliminate depression screening recommendations for pregnant women. It could soften cancer screening guidelines in ways that benefit insurers. None of these outcomes require a formal announcement. They require only that the task force's new membership, selected without independent co-chair oversight, produce recommendations that happen to align with the administration's preferences. The mechanism is quiet. The consequences are not.
The systemic pattern here connects to a broader project. As Kennedy has made clear in his public statements, his vision for American health policy is not grounded in the clinical consensus that has governed preventive medicine for decades. He has questioned vaccines, promoted unproven treatments, and staffed HHS with figures whose relationship to evidence-based medicine ranges from skeptical to hostile. The task force represented the clearest remaining institutional check on that agenda within his own department. It is now subject to his appointment authority, with no independent scientific leadership to govern the transition.
The letters invite Wong and Davis to reapply to serve on the panel as regular members — a detail that functions as either a face-saving gesture or a signal that the administration considers this a routine personnel matter. It is neither. Both were fired mid-term, without cause, immediately before a consequential appointment process. The invitation to reapply for a subordinate role in a body they previously led is not a concession. It is a demonstration of who now holds power over it.
The task force currently has eight active members. New members begin their terms in June. By the time those members are seated — vetted without co-chair oversight, appointed by a secretary who just fired the people who would have reviewed their applications — the body that decides what preventive care 180 million privately insured Americans receive at no cost will have been reconstituted under conditions designed to favor political compliance over scientific independence. The next round of coverage recommendations will tell us what that costs.
